ASND

Ascendis Pharma A/S

150.99

7.66

(5.34%)

Today

As of 4:00 PM Eastern

After Hours:

0DTE

1MO

Today's Expected Move

See where the options market thinks ASND will move between now and market close.

Info News Earnings

Fast Trade

Use the expected move for strike selection. Modify later.

Bullish

Neutral

Range

Bearish

Down

Info News Earnings

Ascendis Pharma A/S

Market Cap: 9.04 billion

PE Ratio: -21.09

Volume: 426.12 thousand

Sector: Healthcare

Industry: Biotechnology

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.